Found 18 clinical trials
Marfan Syndrome (MFS) Medication Study
Marfan Syndrome (MFS) Medication Study
- 99 views
- 25 Mar, 2021
- 1 location
Losartan for Improved Vascular Endothelial Function After Preeclampsia (LIVE-PE)
mechanisms contributing to this lasting blood vessel damage and to test whether taking a medication that blocks angiotensin II receptors (losartan) decrease these negative effects in women who have had
- 10 views
- 26 May, 2022
- 1 location
The Use of Senolytic Agent to Improve the Benefit of Platelet-Rich Plasma and Losartan for Treatment of Femoroacetabular Impingement and Labral Tear: A Pilot Study
The purpose is to explore the possible benefit of administration of Fisetin, (a senolytic agent) to improve the benefit of Platelet-Rich Plasma and losartan for treatment of femoroacetabular
- 0 views
- 22 Oct, 2022
- 1 location
PHL Treatment in Pancreatic Cancer
This proposal will investigate the effect of paricalcitol, hydroxychloroquine, and losartan (PHL) combination of 3 stroma-modifying drugs on pancreatic adenocarcinoma and its stroma.
- 0 views
- 04 Oct, 2022
- 1 location
Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD (WARRIOR)
The Ischemia-IMT (Ischemia-Intensive Medical Treatment Reduces Events in Women with Non-Obstructive CAD), subtitle: Women's Ischemia Trial to Reduce Events in Non-Obstructive CAD (WARRIOR) trial is a multicenter, prospective, randomized, blinded outcome evaluation (PROBE design) evaluating intensive statin/ACE-I (or ARB)/aspirin treatment (IMT) vs. usual care (UC) in 4,422 symptomatic women patients …
- 563 views
- 26 Feb, 2022
- 84 locations
Losartan + Sunitinib in Treatment of Osteosarcoma
This study is a Phase 1/1b clinical trial that aims to determine the Maximally Tolerated Dose of Losartan and Sunitinib Combination Therapy. Patients will first be accrued to the Dose Escalation
- 0 views
- 28 May, 2022
- 2 locations
FOLFIRINOX + 9-Ing-41 + Losartan In Pancreatic Cancer
of the study drugs involved in this study are: 9-ING-41 Losartan Ferumoxytol FOLFIRINOX (made up of 4 different drugs): 5-Fluorouracil (5-FU
- 0 views
- 17 Jun, 2022
- 1 location
Effect of Losartan on Chronic Obstructive Pulmonary Disease (COPD)
Losartan, an angiotensin receptor blocker, has been effective in preventing the development of emphysema and lung inflammation in animal models of COPD. Moreover, there is epidemiologic
- 857 views
- 07 Nov, 2020
- 1 location
Losartan for Diffuse Myocardial Fibrosis in Sickle Cell Disease
This study is a pilot, phase II, open-label study of the angiotensin II receptor blocker, losartan, in patients with Sickle Cell Disease (SCD) 6 years or older for 12 months. The investigators
- 0 views
- 26 Jan, 2022
- 1 location
Imaging Perfusion Restrictions From Extracellular Solid Stress - An Open-label Losartan Study (ImPRESS)
An open-label, single institutional phase II trial of losartan in patients with primary and metastatic brain tumors with an individual stepped-wedge, randomized, assessor-blinded, dose-finding
- 0 views
- 09 May, 2022
- 1 location
- 1
- 2